Dabur India Ltd vs Indo Us Bio Tech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 22, 2026

Key Highlights

The Latest Trading Price of Dabur India Ltd is ₹ 388.35 as of 22 Sep 15:30 . The P/E Ratio of Dabur India Ltd changed from 56.4 on March 2021 to 38.4 on March 2026 . This represents a CAGR of -6.21% over 6 yearsThe P/E Ratio of Indo US Bio-Tech Ltd changed from 4 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Dabur India Ltd changed from ₹ 95564 crore on March 2021 to ₹ 72792 crore on March 2026 . This represents a CAGR of -4.44% over 6 yearsThe Market Cap of Indo US Bio-Tech Ltd changed from ₹ 19.75 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Dabur India Ltd for the Jun '26 is ₹ 3936 crore as compare to the Mar '26 revenue of ₹ 3213 crore. This represent the growth of 22.53% The revenue of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Dabur India Ltd for the Jun '26 is ₹ 913.45 crore as compare to the Mar '26 ebitda of ₹ 635.85 crore. This represent the growth of 43.66% The ebitda of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Dabur India Ltd changed from ₹ 494.35 crore to ₹ 586.16 crore over 9 quarters. This represents a CAGR of 7.87% The net profit of Indo US Bio-Tech Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Dabur India Ltd changed from 60.75 % on March 2021 to 98.13 % on March 2026 . This represents a CAGR of 8.32% over 6 yearsThe Dividend Payout of Indo US Bio-Tech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Dabur India Ltd

Dabur India Limited is one of the leading FMCG Companies in India and a global leader in Ayurveda with a portfolio of over 250 Herbal and Ayurvedic products.
The Company operate in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care and Foods.
Their FMCG portfolio includes five flagship brands with distinct brand identities, 'Dabur' as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Real for fruit juices and beverages and Fem for fairness bleaches and skin care products. The Company operates through three Strategic Business Units, Consumer Care Division (CCD), International Business Division (IBD) and Consumer Health Division (CHD).
Their CCD business is divided into four key portfolios: healthcare, personal care, home care and foods.

About Indo US Bio-Tech Ltd

Indo Us Bio-Tech Limited was originally incorporated as 'Pollucid Bio-Tech Private Limited' at Junagadh on February 4, 2004.
Subsequently, the name was change to 'Pellucid Bio-Tech Private Limited' on January 5, 2005.
Later on, the name of the Company was changed to 'Indo Us Bio-Tech Private Limited' on March 9, 2007.
Consequently, upon conversion into Public Limited Company, the name of the Company was changed to 'Indo Us Bio-Tech Limited' on January 11, 2018. The Company is an ISO 9001-2008 company, involved in crop research & development throw breeding, production of seeds, processing, packing and marketing of high performing hybrid and open pollinated varieties of agricultural crops.
The Company has its seed processing plants located in Gujarat, where the seeds are processed, stored and packed with the help of modern machineries.

FAQs for the comparison of Dabur India Ltd and Indo US Bio-Tech Ltd

Which company has a larger market capitalization, Dabur India Ltd or Indo US Bio-Tech Ltd?

Market cap of Dabur India Ltd is 68,891 Cr while Market cap of Indo US Bio-Tech Ltd is 158 Cr

What are the key factors driving the stock performance of Dabur India Ltd and Indo US Bio-Tech Ltd?

The stock performance of Dabur India Ltd and Indo US Bio-Tech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dabur India Ltd and Indo US Bio-Tech Ltd?

As of September 22, 2026, the Dabur India Ltd stock price is INR ₹388.35. On the other hand, Indo US Bio-Tech Ltd stock price is INR ₹78.99.

How do dividend payouts of Dabur India Ltd and Indo US Bio-Tech Ltd compare?

To compare the dividend payouts of Dabur India Ltd and Indo US Bio-Tech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.